Securities abbreviation: Jiangsu Kanion Pharmaceutical Co.Ltd(600557) securities code: Jiangsu Kanion Pharmaceutical Co.Ltd(600557) Announcement No.: 2022008 Jiangsu Kanion Pharmaceutical Co.Ltd(600557)
Announcement of resolutions of the 10th meeting of the 7th board of supervisors
The board of supervisors and all supervisors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents Jiangsu Kanion Pharmaceutical Co.Ltd(600557) (hereinafter referred to as “the company”) the notice of the 10th meeting of the 7th board of supervisors was sent by telephone and e-mail on February 18, 2022. The meeting was held on site on March 2, 2022. There were 3 supervisors who should participate in the voting and 3 supervisors who actually participated in the voting. The meeting was held in accordance with the provisions of the company law, the articles of association and other laws and regulations. The meeting was presided over by Mr. Yin Shihua, chairman of the board of supervisors. The following proposals were considered and adopted by a show of hands.
1、 The annual report for 2021 and its summary were considered and adopted
In accordance with the relevant provisions and requirements of the securities law, the standards for the contents and forms of information disclosure by companies offering securities to the public No. 2 – Contents and forms of annual reports, and the guidelines for industrial information disclosure by listed companies No. 6 – pharmaceutical manufacturing, the board of supervisors of the company has strictly reviewed the full text and summary of the company’s 2021 annual report prepared by the board of directors, Make the following audit opinions:
1. The preparation and review procedures of the company’s 2021 annual report comply with laws, regulations, the articles of association and various provisions of the company’s internal management system.
2. The content and format of the company’s 2021 annual report comply with the provisions of the China Securities Regulatory Commission and Shanghai Stock Exchange, and the information contained truly reflects the company’s operation, management and financial status in all aspects. 3. Before the board of supervisors put forward this opinion, it was not found that the personnel involved in the preparation and deliberation of the company’s 2021 annual report had violated the confidentiality provisions.
Voting results: 3 in favor, 0 against and 0 abstention.
2、 The work report of the board of supervisors in 2021 was reviewed and adopted
The work of the board of supervisors in 2021 is reported as follows:
(I) work of the board of supervisors
Meeting situation and topics
1. 2020 annual report and its summary
2. Work report of the board of supervisors in 2020
The sixth meeting of the seventh board of supervisors was held on April 9, 2021. 3. Financial final accounts report of 2020
4. Proposal on daily related party transactions in 2021
5. 2020 internal control evaluation report
The seventh meeting of the seventh board of supervisors was held on April 28, 2021. The report of the first quarter of 2021
The eighth meeting of the seventh board of supervisors was held on August 19, 2021. The semi annual report of 2021
The ninth meeting of the seventh board of supervisors was held on October 27, 2021, and the third quarter report of 2021 was submitted
In strict accordance with the relevant provisions of the company law, the articles of association and the rules of procedure of the board of supervisors, and in the attitude of being responsible to all shareholders, the board of supervisors of the company scrupulously abides by its duties, performs its duties diligently, actively carries out various work, earnestly performs its duties of supervising the company’s finance, risk control and directors and senior managers, and strengthens its supervision over the company’s major business decisions The investment plan and the supervision and inspection of the implementation of the resolutions of the general meeting of shareholders by the board of directors and the implementation of the resolutions of the board of directors by the management have effectively promoted the legal operation and standardized operation of the company, and played a positive role in promoting the healthy and steady development of the company and safeguarding the legitimate rights and interests of the company and all shareholders.
(II) independent opinions of the board of supervisors on relevant matters of the company during the reporting period
1. Independent opinions of the board of supervisors on the legal operation of the company
During the reporting period, the board of supervisors conducted corresponding inspection and supervision on the company’s decision-making procedures, internal control system and the performance of the company’s directors, general manager and other senior managers in accordance with the company law and other relevant laws and regulations and the articles of association. The board of supervisors held that during the reporting period, the company operated in strict accordance with relevant national laws and regulations and the relevant provisions of the articles of association, and all internal control systems of the enterprise were standardized and sound without violations. The directors and senior managers of the company do not violate laws, regulations, the articles of association or damage the interests of the company when performing their duties.
2. Independent opinions of the board of supervisors on the inspection of the company’s financial situation
During the reporting period, the board of supervisors supervised, inspected and reviewed the company’s financial system and financial report, and believed that the company’s internal control over financial accounting was sound, and the financial report truly, accurately, completely and comprehensively reflected the company’s financial status and operating results. Lixin Certified Public Accountants (special general partnership) hired by the company audited the company’s 2020 financial report and issued a standard unqualified audit report. The preparation and deliberation procedures of this annual report comply with laws and regulations, the articles of association and the provisions of the company’s internal management system. The content and format of the annual report comply with the provisions of the CSRC and the stock exchange. The information contained truly reflects the company’s operation, management and financial status in all aspects.
3. Independent opinions of the board of supervisors on the acquisition and sale of assets of the company
During the reporting period, the transaction price of the company’s acquisition and sale of assets was reasonable, there was no insider trading, and there was no behavior damaging shareholders’ rights and interests or causing the loss of the company’s assets.
4. Independent opinions of the board of supervisors on the company’s connected transactions
During the reporting period, the related party transactions of the company were conducted at the fair market price. The related party transactions of the company were fair and open, and did not harm the interests of the company and shareholders.
5. Review and opinions of the board of supervisors on the self-evaluation report on internal control
The board of supervisors of the company reviewed the internal control evaluation report of the company in 2020 and believed that the self-evaluation of the company’s internal control met the requirements of the basic norms of enterprise internal control and other relevant documents. The company established and improved the internal control system related to financial reporting and ensured that the information related to financial reporting was true, complete and reliable, The company’s internal control system related to the 2020 financial report is sound and effective.
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal shall be submitted to the 2021 annual general meeting of shareholders for deliberation.
3、 Reviewed and adopted the financial final accounts report of 2021
See section X “financial report” of the company’s 2021 annual report for the company’s 2021 annual report.
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal shall be submitted to the 2021 annual general meeting of shareholders for deliberation.
4、 The proposal on daily connected transactions expected in 2022 was deliberated and adopted
For details, please refer to the website of Shanghai Stock Exchange at www.sse.com on the same day com. cn. The company’s announcement on expected daily connected transactions in 2022 (Announcement No.: 2022011).
Voting results: 2 in favor, 1 in avoidance, 0 against and 0 abstention. (Mr. Yin Shihua, associate supervisor, abstained from voting)
This proposal needs to be submitted to the 2021 annual general meeting of shareholders for deliberation, and related shareholders will avoid voting on this proposal. 5、 The 2021 internal control evaluation report was reviewed and adopted
For details, please refer to the website of Shanghai Stock Exchange at www.sse.com on the same day com. cn. The company’s 2021 internal control evaluation report disclosed.
According to the provisions of the basic norms of enterprise internal control and its supporting guidelines and other internal control supervision requirements, the company has evaluated the effectiveness of internal control as of December 31, 2021 (the benchmark date of internal control evaluation report), prepared the company’s 2021 annual internal control evaluation report, and we reviewed the company’s 2021 annual internal control evaluation report, Consider that the internal control evaluation system of the company meets the relevant requirements and the actual situation of the company; The internal control systems established by the company are actively implemented; The internal control evaluation report of the company in 2021 objectively reflects the real situation of the company’s internal control, and the summary of the company’s internal control is relatively comprehensive.
Voting results: 3 in favor, 0 against and 0 abstention.
It is hereby announced.
Jiangsu Kanion Pharmaceutical Co.Ltd(600557) board of supervisors March 3, 2022
